We very much appreciate to read the letter to the Editor from Drs Pellicano R and Fagoonee S [1] with relevant comments to our recent article [2]. They critically remarked the usefulness and the generalized message encouraging Helicobacter pylori eradication to prevent coronary artery disease (CAD) or its recurrence. Indeed, the lack of association between H. pylori infection and atherosclerotic cardiovascular diseases has also been observed by some papers with conflicting results [3]. However, the data o, significant association between infection in general (H. pylori in particular) and CAD with evidence level III are more frequent than conflicting results. Despite the limitations of our hospital-based data concerning “Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics” [2], of great interest are the case-control and the longitudinal approach of the methods procedure within a homogenous Bantu ethnic group. There were both chronic and acute (stroke, angor pectoris myocardial infarction) atherosclerotic diseases within a specific environment. Atherosclerosis was anecdotally reported in Africa during 1900s, but emerging now with epidemic rates [4]. Established coronary heart disease risk factors account for only about one third of acute events [5] and do not fully explain the temporal and geographical variations in CAD worldwide. Each region of sub-Saharan Africa has its peculiar expressing of epidemiological and clinical features of atherosclerosis [5]. This has fostered the search for causal association between different components of the metabolic syndrome, atherosclerotic cardiovascular diseases and H.